Abstract
Biopsies of castration resistant prostate cancer metastases were subjected to whole genome sequencing (WGS), along with RNA-sequencing (RNA-Seq). The overarching goal of the study is to illuminate molecular mechanisms of acquired resistance to therapeutic agents, and particularly androgen signaling inhibitors, in the treatment of metastatic castration resistant prostate cancer (mCRPC). This study is made available on AWS via the NIH STRIDES Initiative.
Catalogue metadata
- Record ID
- AISLI-R-C322732AF447FD82C20E
- Type
- Datasets
- Source catalogue
- registry.opendata.aws
- الموضوع
- 生命科学与生物医学
- شروط الاستخدام
- NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies